Allergan Strikes $200M Deal To Exit NY Opioid Trial
Allergan has reached a settlement worth up to $200 million to end its participation in a closely watched New York opioid trial brought by state and county governments, according to a Wednesday announcement....To view the full article, register now.
Already a subscriber? Click here to view full article